Anchiano Therapeutics Ltd.
(UNKNOWN : ANCN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.10%178.011.3%$463.19m
CELGCelgene Corporation
0.93%97.411.3%$422.02m
GILDGilead Sciences, Inc.
1.21%67.160.9%$393.18m
BIIBBiogen Inc.
1.88%231.961.3%$354.08m
ILMNIllumina, Inc.
0.93%347.203.5%$270.44m
REGNRegeneron Pharmaceuticals, Inc.
1.46%309.702.6%$232.33m
AAgilent Technologies, Inc.
0.17%70.091.6%$212.44m
VRTXVertex Pharmaceuticals Incorporated
1.65%173.021.9%$197.38m
ARRYArray BioPharma Inc.
56.05%46.188.2%$185.01m
EXASExact Sciences Corporation
0.72%110.5725.3%$184.19m
ALXNAlexion Pharmaceuticals, Inc.
2.34%120.692.0%$176.19m
BMRNBioMarin Pharmaceutical Inc.
4.24%84.274.3%$136.36m
MRTXMirati Therapeutics Inc.
6.14%100.052.5%$113.59m
IONSIonis Pharmaceuticals, Inc.
3.50%64.268.2%$96.35m
INCYIncyte Corporation
4.71%81.372.5%$91.41m

Company Profile

Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.